Physician profile
Cassie Alexander
NPI 1508147844
$939.53
in general payments reported to CMS, 2019-2025
10 companies · $49.27 in 2025
The $49.27 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $248 · 2023: $283 · 2024: $137 · 2025: $49.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $352.07 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $215.87 | 2022-2024 | Xarelto |
| Pfizer INC. | $138.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $74.98 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $56.50 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $44.81 | 2021-2025 | Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.76 | 2025 | Xifaxan |
| Novo Nordisk INC | $12.72 | 2023 | Ozempic, Rybelsus |
| Lemaitre Vascular, INC. | $12.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassie Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.